Markets

Cerner Enjoys Industry Recognitions, Wins EHNAC Accredition - Analyst Blog

Multiple stacks of coins
Credit: Shutterstock photo

Cerner Corp.CERN has added yet another feather to its cap. The company recently achieved full accreditation with the Direct Trusted Agent Accreditation Program (DTAAP), close on the heels of being recognized as the top performing enterprise HIE supplier.

Cerner has received full accreditation with DTAAP from DirectTrust and the Electronic Healthcare Network Accreditation Commission (EHNAC) for its Health Information Service Provider (HISP).

DTAAP which is endorsed by the Office of the National Coordinator for Health Information Technology (ONC), acknowledges organizations that accomplish superior health data processing and transactions. The program also assesses the extent to which a company in question complies with industry-established standards, HIPAA regulations and the Direct Project.

EHNAC, through the review process, has appraised Cerner in different areas like privacy, security and confidentiality; technical performance; business practices and organizational resources. EHNAC also studied the procedure through which the company manages and transfers protected health information. Eventually, after successful evaluation, the accreditation was granted to Cerner.

Recently, Cerner was acknowledged by Black Book Rankings' 2015 health information exchange (HIE) User Survey as the top performing enterprise HIE supplier for inpatient/ambulatory health information technology. This is the third time that the company has been adjudged with the said designation.

In Jan 2015, Cerner won six Best in KLAS 2014 awards including "Best in KLAS" Remote Hosting. Cerner has received the "Best in KLAS" Remote Hosting recognition for the sixth consecutive year. Cerner has also been acknowledged as the KLAS Category Leader in Anatomic Pathology for the fourth year in a row. The annual KLAS report is usually based on feedback from thousands of health care providers globally that rank health care suppliers.

We feel such back-to-back industry recognitions will work in Cerner's favor, allowing it to gain greater visibility and subsequent market traction, going forward. The acclaims should fuel greater adoption of the company's product and services, and eventually drive top-line growth.

Zacks Rank

Currently, Cerner has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical sector are LeMaitre Vascular LMAT , SurModics SRDX and Capricor Therapeutics CAPR . While LeMaitre Vascular and SurModics sport a Zacks Rank #1 (Strong Buy), Capricor Therapeutics holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CERNER CORP (CERN): Free Stock Analysis Report

SURMODICS (SRDX): Free Stock Analysis Report

LEMAITRE VASCLR (LMAT): Get Free Report

CAPRICOR THERAP (CAPR): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CERN SRDX LMAT CAPR

Other Topics

Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More